Clinical trial
Prophylactic Vaccines as Therapy: Prevention of Recurrence of Extensive Genital Warts
NCT02750202 is registered in ClinicalTrials.gov with University of Pretoria as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prophylactic Vaccines as Therapy: Prevention of Recurrence of Extensive Genital Warts
- Lead sponsor
- University of Pretoria
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- July 1, 2018
- Completion date
- July 31, 2025
- Enrollment
- 52 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
genital warts